KR100523732B1 - Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드 - Google Patents

Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드

Info

Publication number
KR100523732B1
KR100523732B1 KR10-2004-0067720A KR20040067720A KR100523732B1 KR 100523732 B1 KR100523732 B1 KR 100523732B1 KR 20040067720 A KR20040067720 A KR 20040067720A KR 100523732 B1 KR100523732 B1 KR 100523732B1
Authority
KR
South Korea
Prior art keywords
hbv
plasmid
variable region
human antibodies
antibodies against
Prior art date
Application number
KR10-2004-0067720A
Other languages
English (en)
Other versions
KR20040084875A (ko
Inventor
김세호
송승환
김연재
천지현
박송용
Original Assignee
주식회사 녹십자홀딩스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 녹십자홀딩스 filed Critical 주식회사 녹십자홀딩스
Priority to KR10-2004-0067720A priority Critical patent/KR100523732B1/ko
Publication of KR20040084875A publication Critical patent/KR20040084875A/ko
Application granted granted Critical
Publication of KR100523732B1 publication Critical patent/KR100523732B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR10-2004-0067720A 2004-08-27 2004-08-27 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드 KR100523732B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2004-0067720A KR100523732B1 (ko) 2004-08-27 2004-08-27 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2004-0067720A KR100523732B1 (ko) 2004-08-27 2004-08-27 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0002190A Division KR100467706B1 (ko) 2002-01-15 2002-01-15 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체

Publications (2)

Publication Number Publication Date
KR20040084875A KR20040084875A (ko) 2004-10-06
KR100523732B1 true KR100523732B1 (ko) 2005-10-26

Family

ID=37368181

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-0067720A KR100523732B1 (ko) 2004-08-27 2004-08-27 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드

Country Status (1)

Country Link
KR (1) KR100523732B1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011040668A1 (en) 2009-09-29 2011-04-07 Green Cross Corporation Antibodies specifically binding to the epidermal growth factor receptor

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090056537A (ko) * 2007-11-30 2009-06-03 주식회사 녹십자 Ｂ형 간염 바이러스 중화능을 갖는 항체를 유효성분으로포함하는 ｂ형 간염 바이러스 감염의 예방 또는 치료용조성물
KR101072895B1 (ko) 2009-12-24 2011-10-17 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원에 특이적으로 결합하는 인간 항체

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011040668A1 (en) 2009-09-29 2011-04-07 Green Cross Corporation Antibodies specifically binding to the epidermal growth factor receptor

Also Published As

Publication number Publication date
KR20040084875A (ko) 2004-10-06

Similar Documents

Publication Publication Date Title
HK1217713A1 (zh) 血管生成素- 的抗體及其應用
EP1758595A4 (en) Use of lipid conjugates in the treatment of diseases
IL182643A0 (en) Novel composition and methods for the treatment of immune related diseases
PL1800693T3 (pl) Terapia adiuwantowa z zastosowaniem przeciwciała przeciw glipikanowi 3
IL178593A (en) Specific antibodies of fcγriib and methods for their use
HK1099935A1 (en) Anti-cd3 antibodies and methods of use thereof -cd3
EP2023955A4 (en) Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
EP1773388A4 (en) SARS VACCINES AND METHODS OF PRODUCING VERY POWERFUL ANTIBODIES
PL2689767T3 (pl) Kompozycje i sposoby ich stosowania do poprawy stanu i wyglądu skóry
EP1720575A4 (en) Therapeutic and diagnostic conjugates for use with multi-specific antibodies
HRP20140271T1 (hr) Humana antitijela protiv bjesnoä†e i njihova uporaba
EP1789034A4 (en) COMPOUNDS HAVING A DIPHENYL STRUCTURE FOR THE TREATMENT OF IMMUNE DISEASES
EP2185202A4 (en) USE OF INTERLEUKIN-22 FOR THE TREATMENT OF FATTLEBER
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
GB0718843D0 (en) Materials and methods relating to modifying the binding of antibodies
EP1789027A4 (en) Therapeutic Use of Anti- TF Antigen Antibodies
PT1766098E (pt) Anticorpos monoclonais de coelho para antigénios de superfície da hepatite b e métodos para utilizar os mesmos
IL212215A0 (en) Use of lipid conjugates in the treatment of disease
HK1155670A1 (en) Therapeutic use of anti-cs1 antibodies
KR100523732B1 (ko) Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체의가변영역을 삽입할 수 있는 항체발현 플라스미드
ZA200803664B (en) Chimeric antigens and vaccines
GB2426759B (en) An improved and eco-friendly process for the preparation of 2-chlorenbenzylidene malononitrile
IL181228A0 (en) Vlp-antigen conjugates and their uses as vaccines
PL115706U1 (en) Commemorative object made of natural stone
IL229980A0 (en) Use of fatty conjugates to treat diseases

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121011

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20130911

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20140911

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20151008

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20161010

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20181011

Year of fee payment: 14